| # | Title | Journal | Year | Citations |
|---|
| 1 | Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus | Nature Genetics | 2010 | 351 |
| 2 | Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders | Journal of Allergy and Clinical Immunology | 2017 | 261 |
| 3 | Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1 | Nature Communications | 2015 | 220 |
| 4 | Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases | Nature Medicine | 2015 | 212 |
| 5 | Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy | PLoS Genetics | 2011 | 201 |
| 6 | The EuroMyositis registry: an international collaborative tool to facilitate myositis research | Annals of the Rheumatic Diseases | 2018 | 183 |
| 7 | The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements | Lancet Rheumatology, The | 2020 | 182 |
| 8 | Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis | Arthritis Research and Therapy | 2017 | 174 |
| 9 | Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial | Lancet, The | 2016 | 168 |
| 10 | Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database | Annals of the Rheumatic Diseases | 2021 | 160 |
| 11 | Disease progression into adulthood and predictors of long-term active disease in juvenile idiopathic arthritis | Annals of the Rheumatic Diseases | 2016 | 153 |
| 12 | A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility | American Journal of Human Genetics | 2015 | 144 |
| 13 | Predictors of progression in systemic sclerosis patients with interstitial lung disease | European Respiratory Journal | 2020 | 134 |
| 14 | Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups | Annals of the Rheumatic Diseases | 2016 | 127 |
| 15 | Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs) | Annals of the Rheumatic Diseases | 2021 | 120 |
| 16 | Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course | Journal of Clinical Medicine | 2019 | 118 |
| 17 | Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial | Lancet Respiratory Medicine,the | 2021 | 118 |
| 18 | Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort | Annals of the Rheumatic Diseases | 2015 | 106 |
| 19 | Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort | Scandinavian Journal of Gastroenterology | 2015 | 105 |
| 20 | Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model | Annals of the Rheumatic Diseases | 2018 | 100 |
| 21 | GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways | Nature Communications | 2019 | 100 |
| 22 | Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study | Lupus | 2014 | 90 |
| 23 | Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study | Annals of the Rheumatic Diseases | 2018 | 89 |
| 24 | A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis | American Journal of Human Genetics | 2017 | 78 |
| 25 | Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis | Journal of the American College of Cardiology | 2018 | 78 |
| 26 | Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts | BMJ Open Gastroenterology | 2017 | 77 |
| 27 | Dysbiotic salivary microbiota in dry mouth and primary Sjögren’s syndrome patients | PLoS ONE | 2019 | 74 |
| 28 | High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis | Chest | 2016 | 73 |
| 29 | Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study | Annals of the Rheumatic Diseases | 2010 | 69 |
| 30 | Proteomic and histopathological characterisation of sicca subjects and primary Sjögren’s syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers | Arthritis Research and Therapy | 2019 | 65 |
| 31 | A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort | Annals of the Rheumatic Diseases | 2011 | 63 |
| 32 | Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients | Scandinavian Journal of Rheumatology | 2011 | 60 |
| 33 | Genetic sharing and heritability of paediatric age of onset autoimmune diseases | Nature Communications | 2015 | 58 |
| 34 | A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis | Annals of the Rheumatic Diseases | 2010 | 55 |
| 35 | Oral distress in primary Sjögren’s syndrome: implications for health-related quality of life | European Journal of Oral Sciences | 2011 | 55 |
| 36 | Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial | Rheumatology | 2011 | 55 |
| 37 | Oral disorders, saliva secretion, and oral health‐related quality of life in patients with primary Sjögren's syndrome | European Journal of Oral Sciences | 2017 | 55 |
| 38 | Elevated cytokine levels in tears and saliva of patients with primary Sjögren’s syndrome correlate with clinical ocular and oral manifestations | Scientific Reports | 2019 | 54 |
| 39 | Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis | British Journal of Dermatology | 2011 | 53 |
| 40 | TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study | Arthritis Research and Therapy | 2017 | 53 |
| 41 | Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey | Advances in Therapy | 2021 | 53 |
| 42 | Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study | Journal of Crohn's and Colitis | 2018 | 52 |
| 43 | OX40L blockade protects against inflammation-driven fibrosis | Proceedings of the National Academy of Sciences of the United States of America | 2016 | 50 |
| 44 | Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era | BMC Musculoskeletal Disorders | 2014 | 49 |
| 45 | Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial | PLoS ONE | 2020 | 47 |
| 46 | Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial | Arthritis and Rheumatology | 2022 | 44 |
| 47 | Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease | Expert Review of Clinical Immunology | 2019 | 42 |
| 48 | High incidence and prevalence of systemic lupus erythematosus in Norway | Lupus | 2012 | 36 |
| 49 | Influence of theIL17A locusin giant cell arteritis susceptibility | Annals of the Rheumatic Diseases | 2014 | 36 |
| 50 | Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides | Rheumatology | 2019 | 36 |
